4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Theravance Biopharma, Inc. (TBPH) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 90 employees. Its market capitalization is roughly $880 million. In the fiscal year ended 2025-12-31, TBPH reported $108M in revenue and $106M in net income.
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States.
Interactive charts & full statements → Open the TBPH valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $108M | $64M | $57M | $51M | — |
| Operating Income (EBIT) | ($4M) | ($42M) | ($53M) | ($79M) | — |
| Net Income | $106M | ($56M) | ($55M) | $872M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $18M | $46M | $20M | $26M | $15M | — |
| Operating Income (EBIT) | ($6M) | $20M | ($6M) | ($3M) | ($14M) | — |
| Net Income | ($5M) | $61M | $4M | $55M | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $486M | $354M | $382M | $607M | — |
| Total Liabilities | $189M | $179M | $169M | $166M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TBPH viewer.
About TickerBase · Data methodology & sources